Carbapenem-resistant Acinetobacter baumannii from Brazil: role of carO alleles expression and blaOXA-23 gene

BMC Microbiology

Ana Carolina P Vicente¹  Rosângela Cipriano²  Fernanda S Freitas¹  Erica Scheidegger¹  Erica Lourenço Fonseca¹ 

[1] Laboratório de Genética Molecular de Microrganismos, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil;Departamento de Medicina 1, Universidade Federal do Maranhão, São Luís, Maranhão, Brazil

关键词: Brazil;    Acinetobacter;    Imipenem resistance;    Expression;    OXA-23;    CarO;   

Others  :  1142776
DOI  :  10.1186/1471-2180-13-245

 received in 2013-07-02, accepted in 2013-10-18,  发布年份 2013

【 摘 要 】

Background

Carbapenems are the antibiotics of choice to treat infections caused by Acinetobacter baumannii, and resistance to this class can be determined by loss of membrane permeability and enzymatic mechanisms. Here, we analyzed the basis of carbapenem resistance in clinical A. baumannii isolates from different Brazilian regions.

Results

The analyses addressed the carbapenemase activity of OXA-23, CarO expression and alterations in its primary structure. Susceptibility test revealed that the strains presented the COS (Colistin-Only-Sensitive) profile. PCR and sequencing showed the presence of the chromosomally-encoded bla_OXA-51 in all isolates. The majority of strains (53%) carried the carbapenemase bla_OXA-23 gene associated with ISAba1. The Hodge test indicated that these strains are carbapenemase producers. PFGE revealed 14 genotypes among strains from Rio de Janeiro and Maranhão. The influence of carO on imipenem resistance was evaluated considering two aspects: the composition of the primary amino acid sequence; and the expression level of this porin. Sequencing and in silico analyses showed the occurrence of CarOa, CarOb and undefined CarO types, and Real Time RT-PCR revealed basal and reduced carO transcription levels among isolates.

Conclusions

We concluded that, in general, for these Brazilian isolates, the major carbapenem resistance mechanism was due to OXA-23 carbapenemase activity and that loss of CarO porin plays a minor role in this phenotype. However, it was possible to associate the carO alleles and their expression with imipenem resistance. Therefore, these findings underline the complexity in addressing the role of different mechanisms in carbapenem resistance and highlight the possible influence of CarO type in this phenotype.

【 授权许可】

   
2013 Fonseca et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Boucher HW, Talbot GH, Bradley JS, Edwards JE Jr, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J: Bad bugs, No drugs: No ESKAPE! an update from the infectious diseases society of America. Clin Infect Dis 2009, 48:1-12.
• [2]Kuo HY, Chang KC, Kuo JW, Yueha HW, Liouf ML: Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii. Int J Antimicrob Agents 2012, 39:33-38.
• [3]Poirel L, Nordmann P: Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006, 12:826-836.
• [4]Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, Pitt TL: The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006, 258:72-77.
• [5]Werneck JS, Picão RC, Girardello R, Cayô R, Marguti V, Dalla-Costa L, Gales AC, Antonio CS, Neves PR, Medeiros M, Mamizuka EM, Elmor de Araújo MR, Lincopan N: Low prevalence of blaOXA-143 in private hospitals in Brazil. Antimicrob Agents Chemother 2011, 55:4494-4495.
• [6]Mostachio AK, Levin AS, Rizek C, Rossi F, Zerbini J, Costa SF: High prevalence of OXA-143 and alteration of outer membrane proteins in carbapenem-resistant Acinetobacter spp. isolates in Brazil. Int J Antimicrob Agents 2012, 39:396-401.
• [7]Pagano M, Martins AF, Machado AB, Barin J, Barth AL: Carbapenem-susceptible Acinetobacter baumannii carrying the ISAba1 upstream blaOXA-51-like gene in Porto Alegre, southern Brazil. Epidemiol Infect 2012, 19:1-4.
• [8]Mussi MA, Relling VM, Limansky AS, Viale AM: CarO, an Acinetobacter baumannii outer membrane protein involved in carbapenem resistance, is essential for L-ornithine uptake. FEBS Lett 2007, 581:5573-5578.
• [9]Catel-Ferreira M, Coadou G, Molle V, Mugnier P, Nordmann P, Siroy A, Jouenne T, Dé E: Structure-function relationships of CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii. J Antimicrob Chemother 2011, 66:2053-2056.
• [10]Fonseca EL, Fdos Freitas S, Scheidegger ÉM, Jacinto T, Vicente AC: Class 2 integrons in multidrug-resistant Acinetobacter baumannii circulating in different Brazilian geographic regions. Int J Antimicrob Agents 2011, 38:95-96.
• [11]Corvec S, Poirel L, Naas T, Drugeon H, Nordmann P: Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii. Antimicrob Agents Chemother 2007, 51:1530-1533.
• [12]Higgins PG, Dammhayn C, Hackel M, Seifert H: Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 2010, 65:233-238.
• [13]Mugnier P, Poirel L, Naas T, Nordmann P: Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 2010, 16:35-40.
• [14]Zarrilli R, Pournaras S, Giannouli M, Tsakris A: Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents 2013, 41:11-19.
• [15]Mussi MA, Limansky AS, Viale AM: Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of beta-barrel outer membrane proteins. Antimicrob Agents Chemother 2005, 49:1432-1440.
• [16]Vashist J, Tiwari V, Kapil A, Rajeswari MR: Quantitative profiling and identification of outer membrane proteins of beta-lactam resistant strain of Acinetobacter baumannii. J Proteome Res 2010, 9:1121-1128.
• [17]CLSI: Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Wayne, PA: M100-S21. Clinical and Laboratory Standards Institute; 2011.
• [18]Lee K, Kim CK, Yong D, Jeong SH, Yum JH, Seo YH, Docquier JD, Chong Y: Improved performance of the modified hodge test with MacConkey agar for screening carbapenemase-producing gram-negative bacilli. J Microbiol Methods 2010, 83:149-152.
• [19]Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B: Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.